当前位置: X-MOL首页全球导师 国内导师 › 聂志余

个人简介

在研课题 A型肉毒毒素治疗难治性雷诺现象单中心、随机、双盲、安慰剂对照临床研究,上海市科学技术委员会中西医引导类项目,项目编号:18411961600,主持2018.9.30-2021.9.30 帕金森病“肠-脑转移”轴分子病理机制研究,国家自然科学基金面上项目,项目批准号:81974196,主持,2020.1-2023.12 上海市科委重大专项,急性缺血性卒中救治优化方案的临床多中心研究,分中心负责,20201113-20240930

研究领域

脑血管病

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

闫斌、朱明振,刘远洪,聂志余*.脑静脉都血栓形成早发性痫性发作影响因素研究,中国卒中杂志,2017:12(3):214-218. Fei Chen, Lingjing Jin, Zhiyu Nie*. Safety and Efficacy of Rotigotine for Treating Parkinson’s Disease: A Meta-Analysis of Randomised Controlled Trials. J Pharm Pharm Sci. 2017 May 20, 285 – 294. Ya Feng, Wuchao Liu, Lizhen Pan, Cong Jiang, Chengxi Zhang, Yuxuan Lu, Zhiyu Nie*, Lingjing Jin. Comparison of neurotoxic potency betweena novel chinbotulinumtoxinA withonabotulinumtoxinA, incobotulinumtoxinA and lanbotulinumtoxinA in rats. Drug Design, Development and Therapy. 2017 June 28:1927-1939. 管强,赵丽娟,靳令经,聂志余*.帕金森病患者跌倒恐惧的多因素分析.中华老年心脑血管病杂志2017年8月第19卷 第8期,802-805. 项美玲,聂志余*.脑分水岭梗死的CT应用研究进展,同济大学学报(医学版),2017,38(6):117-125. Huang J, Li J, Feng C, Huang X, Wong L, Liu X, Nie Z*, Xi G. Blood-Brain Barrier Damage as the Starting Point of Leukoaraiosis Caused by Cerebral ChronicHypoperfusion and Its Involved Mechanisms: Effect of Agrin and Aquaporin-4. Biomed Res Int. 2018 Feb 26;2018:2321797. doi: 10.1155/2018/2321797. eCollection 2018. 何育生,封亮,江虹,李云霞,张旭,聂志余*.扣带束和钩束的微观结构变化与白质疏松相关性抑郁.中风与神经疾病杂志,2018,35(2):127-130. Yanwen Zhou, Ying Liu, Yunhua Hao,Ya Feng, Lizhen Pan, Wuchao Liu, Bin Li, Libin Xiao, Lingjing Jin, Zhiyu Nie*. The mechanism of botulinum A on Raynaud syndrome.Drug Design, Development and Therapy.2018:12 1-11. Meng Liu* ,Zhi-Yu Nie*,Ren-Ren Li,Wei Zhang,Hui Wang,Yu-Sheng He,Li-Juan Zhao,Yun-Xia Li*. Correlation of Brain Perfusion with White Matter Hyperintensity, Brain Atrophy, and Cognition in Patients with Posterior Cerebral Artery Stenosis and Subjective Cognitive Decline. Med Sci Monit. 2018 Aug 17;24:5729-5738. 叶军,乔莉莉,侯双兴,肖伟忠,王清华,聂志余*.丁苯酞软胶囊联合高压氧治疗血管性痴呆的临床疗效及其对血浆同型半胱氨酸水平的影响,实用心脑肺血管病杂志,2018,26(11):106-108. 郑国将,卓子良,于婷,刘渊华,徐建华,李云霞,聂志余*,ASPECTS、DRAGON和THRIVE评分对我国接受静脉溶栓治疗的急性缺血性卒中患者3个月不良预后的预测价值分析,中国卒中杂志,2019,14(6):541-548. 聂志余.急性缺血性卒中早期血管再通治疗的预后预测模型研究,中国卒中杂志,2019,14(6):585. 聂志余.急性缺血性卒中血管再通治疗的预后预测模型.中国卒中杂志,2019,14(6):523-526. 郑国将,卓子良,聂志余*.急性缺血性卒中血管再通治疗不良预后的预测研究进展.中国卒中杂志,2019,14(6):586-593. 张盼盼,刘远洪, 闫斌,刘素梅,葛晓航,牛智领,刘乐喜,聂志余*.基于磁敏感加权成像的pc-ASPECTS评分对后循环急性缺血性卒中预后的预测价值.中国卒中杂志,2019,14(6):527-532. 郑国将, 毛相濡,丁刚玉,王星,徐建华,靳令经,聂志余*.探讨ASPECTS、DRAGON和SEDAN评分对我国急性缺血性卒中患者静脉溶栓后急性期内出血转化的预测价值.中国卒中杂志,2019,14(6):533-540. Hui Wang#, Zhi-Yu Nie*, Meng Liu, Ren-Ren Li, Li-He Huang, Zhen Lu, Ling-Jing Jin, Yun-Xia Li(聂主任共一,李主任通讯)* .Clinical characteristics of perivascular space and brain CT perfusion in stroke-free patients with carotid plaque. Int J Clin Exp Med 2019;12(5):5033-5041. (SCI收录 IF=0.181) Hui Wang, Zhi-Yu Nie*,Meng Liu, Ren-Ren Li,Li-He Huang,Zheng Lu,Ling-Jing Jin,Yun-Xia Li.Clinical characteristics of perivascular space and brain CT perfusion in stroke-free patients with intracranial and extracranial therosclerosis of different extents,Ann Transl Med 2020;8(5):215 闫斌、刘素梅、张盼盼、李卫君、朱明振、刘远洪、聂志余*.阿加曲班联合丁苯酞对分水岭梗死的疗效及神经元特异性烯醇化酶水平的影响,卒中与神经疾病,2020,27(1):89-92. 卓子良、聂志余*、刘渊华、郑国将、毛相濡、刘梦、刘务朝.急性缺血性卒中患者脑小血管病总负荷与静脉溶栓治疗转归的关系研究,中国卒中杂志,2020,15(7):734-739. Yunxia Li*, Xin Wang, Meng Liu, Wei Zhang, Renren Li, Zhiyu Nie*.Effect of Methylene Blue and PI3K-Akt Pathway Inhibitors on the Neurovascular System after Chronic CerebralHypoperfusion in Rats. Journal of Molecular Neuroscience. DOI 10.1007/s12031-020-01572-1.08 June 2020

推荐链接
down
wechat
bug